These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

880 related items for PubMed ID: 9868993

  • 1. Preventing end-stage renal disease.
    Mogensen CE.
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [Abstract] [Full Text] [Related]

  • 2. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [Abstract] [Full Text] [Related]

  • 3. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K, Thompson C.
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [Abstract] [Full Text] [Related]

  • 4. [Risk and prevention of diabetic nephropathy].
    Ravera M, Re M, Deferrari G.
    G Ital Nefrol; 2007 Aug; 24 Suppl 38():13-9. PubMed ID: 17922442
    [Abstract] [Full Text] [Related]

  • 5. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.
    Halimi JM.
    Diabetes Metab; 2012 Oct; 38(4):291-7. PubMed ID: 22622176
    [Abstract] [Full Text] [Related]

  • 6. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
    Mogensen CE.
    J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
    [Abstract] [Full Text] [Related]

  • 7. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R, Brocco E.
    Exp Clin Endocrinol Diabetes; 1997 Jul; 105 Suppl 2():1-7. PubMed ID: 9288531
    [Abstract] [Full Text] [Related]

  • 8. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
    So WY, Ozaki R, Chan NN, Tong PC, Ho CS, Lam CW, Ko GT, Chow CC, Chan WB, Ma RC, Chan JC.
    Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
    [Abstract] [Full Text] [Related]

  • 9. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 10. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH.
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [Abstract] [Full Text] [Related]

  • 11. Evolving strategies for renoprotection: diabetic nephropathy.
    Parving HH, Hovind P, Rossing K, Andersen S.
    Curr Opin Nephrol Hypertens; 2001 Jul; 10(4):515-22. PubMed ID: 11458033
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R, Tonolo G.
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [Abstract] [Full Text] [Related]

  • 13. How to protect the kidney in diabetic patients: with special reference to IDDM.
    Mogensen CE.
    Diabetes; 1997 Sep; 46 Suppl 2():S104-11. PubMed ID: 9285510
    [Abstract] [Full Text] [Related]

  • 14. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G, Macia M, Ruggenenti P.
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diabetic nephropathy.
    Ibrahim HA, Vora JP.
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Jul; 13(2):239-64. PubMed ID: 10761865
    [Abstract] [Full Text] [Related]

  • 19. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B, Berland Y.
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G, Chaturvedi N.
    Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.